Learn more about Genomic Health's diagnostic tests for breast, colon and prostate cancer, which can help patients and their doctor make better, more informed treatment decisions.
DCIS / Stage 0 breast cancer affects 1 out of every 5 women diagnosed with breast cancer in the U.S. Not all DCIS patients will benefit from the addition of radiation therapy to their treatment. Learn more about the Oncotype DX test for DCIS.
For over a decade, Genomic Health has made genomics an indispensable part of cancer care. Now, we are using next generation technology to transform patient management throughout the cancer journey: from diagnosis to treatment, and monitoring for recurrence. Learn more about how we are making cancer treatment smarter today and tomorrow.
Urology Practice Publishes Study Showing Oncotype DX® Increases Use of Active Surveillance in Prostate Cancer P...
Genomic Health to Announce Second Quarter 2015 Financial Results and Host Conference Call on Tuesday, August 4, 2015
All press releases